Tafenoquine
- CAS No.
- 106635-80-7
- Chemical Name:
- Tafenoquine
- Synonyms
- Krintafe;Tafenoquine;SB252263-AAB;SB 252263-AAB;tafenoquine,Etaquine,WR 238605,SB-252263;WR-238605, WR 238605, WR238605, SB-252263-AAB;WR 238605; WR238605; WR-238605; SB-252263; SB 252263; SB252263;4-[5-[3-(Trifluoromethyl)phenoxy]-2,6-dimethoxy-4-methyl-8-quinolinylamino]-1-pentanamine;N4-{2,6-Dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl}-1,4-pentanediamine;N4-(2,6-diMethoxy-4-Methyl-5-(3-(trifluoroMethyl)phenoxy)quinolin-8-yl)pentane-1,4-diaMine
- CBNumber:
- CB51075086
- Molecular Formula:
- C24H28F3N3O3
- Molecular Weight:
- 463.49
- MDL Number:
- MFCD00598712
- MOL File:
- 106635-80-7.mol
| Melting point | 60 - 63°C |
|---|---|
| Boiling point | 565.6±50.0 °C(Predicted) |
| Density | 1.237±0.06 g/cm3(Predicted) |
| storage temp. | 4°C |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| pka | 10.36±0.10(Predicted) |
| form | Solid |
| color | Dark Orange to Very Dark Orange |
| FDA UNII | 262P8GS9L9 |
| ATC code | P01BA07 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H315-H319-H335 | |||||||||
| Precautionary statements | P261-P305+P351+P338 | |||||||||
| NFPA 704 |
|
Tafenoquine price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| TRC | T004765 | Tafenoquine | 106635-80-7 | 25mg | $530 | 2021-12-16 | Buy |
| TRC | T004765 | Tafenoquine | 106635-80-7 | 50mg | $1010 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | API0015866 | N-(5-AMINOPENTAN-2-YL)-2,6-DIMETHOXY-4-METHYL-5-[3-(TRIFLUOROMETHYL)PHENOXY]QUINOLIN-8-AMINE 95.00% | 106635-80-7 | 5MG | $495.34 | 2021-12-16 | Buy |
| CSNpharm | CSN20176 | Tafenoquine | 106635-80-7 | 25mg | $606 | 2021-12-16 | Buy |
| CSNpharm | CSN20176 | Tafenoquine | 106635-80-7 | 1mg | $132 | 2021-12-16 | Buy |
Tafenoquine Chemical Properties,Uses,Production
Uses
Tafenoquine is a pharmaceutical developed for the treatment of Plasmodium vivax malaria. Tafenoquine is also being explored for pharmaceutical use for inhibition of Toxoplasma gondii growth.
Definition
ChEBI: N(4)-{2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl}pentane-1,4-diamine is an aminoquinoline that is 8-aminoquinoline which is substituted by methoxy groups at positions 2 and 6, a methyl group at position 4, and a m-(trifluoromethyl)phenoxy group at position 5, and in which the amino substituent at position 8 is itself substituted by a 5-aminopentan-2-yl group. It is a member of (trifluoromethyl)benzenes, an aminoquinoline, an aromatic ether, a primary amino compound and a secondary amino compound.
Pharmaceutical Applications
Etaquine. A synthetic 8-aminoquinoline, formulated as the
succinate for oral administration. Tafenoquine is an effective
schizonticide against P. falciparum and P. vivax. It is also
active against the pre-erythrocytic stages of these species and
the hypnozoites of P. vivax. A dosage of 100 mg base corresponds
to 125 mg salt. Oral absorption is slow with a maximum
plasma concentration reached after 12 h. The half-life is
2 weeks, significantly longer than that of primaquine. It is not
eliminated via the kidneys. Toxicity and side effects are similar
to those of primaquine. Development of methemoglobinemia
is common. Patients with G6PD deficiency may develop
severe hemolysis.
It is in clinical development for the treatment and prophylaxis
of P. vivax malaria and for the treatment of P. falciparum
infection.
Tafenoquine Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6313 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6393 | 58 |
| LEAPCHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 43348 | 58 |
| WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. | 17702719238 17702719238 | sales@sun-shinechem.com | China | 905 | 64 |
| Shanghai Luofa Biochemical Technology Co., Ltd. | 021-51111890 15317326293 | sales@molnova.com | China | 4196 | 58 |
| Syntechem Co.,Ltd | info@syntechem.com | China | 12990 | 57 | |
| Beijing HuaMeiHuLiBiological Chemical | 010-56205725 | waley188@sohu.com | China | 12338 | 58 |
| Shanghai Hekang Biotechnology Co., Ltd. | 18939837085 | youchemicals@gmail.com | China | 1813 | 55 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 18892239720 | psaitong@jm-bio.com | China | 12308 | 58 |
Related articles
- The synthesize method of tafenoquine
- A century-long history in 8-aminoquinolines, the only anti-malaria drug class preventing malaria relapse, has resulted in the ....
- Dec 21，2023